SWOG clinical trial number
S0108

Bevacizumab (rhuMAb) (NSC 704865) Therapy For Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma

87% Accrual
Accrual
87%
Closed
Phase
87% Accrual
Accrual
87%
Published
Abbreviated Title
NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL
Activated
04/15/2001
Closed
12/01/2004
Participants
NCORP, Members, Medical Oncologists, Pathologists

Research committees

Lymphoma

Treatment

Bevacizumab

Other Clinical Trials

S2308
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
08/01/2024
21% Accrual
Accrual
21%
Open
Phase
CTSU/AHOD2131
SWOG Clinical Trial Number